New Technologies Expedite Timeframe from Screening to Intervention for Patients with Lung Cancer – Yahoo Finance
CHICAGO, Nov. 10, 2022 /PRNewswire/ — Lung cancer is the leading cause of cancer deaths in the U.S. This is largely because lung cancer symptoms show up in later stages after the cancer has already spread. Thankfully, lung cancer screening is available to detect cancer at early stages. Through a new campaign, the American Lung Association is educating Americans on the benefits of early detection and new methods of managing lung cancer.
To improve early detection of lung cancer, the American Lung Association launched a new educational campaign.
Close to 236,000 people will be diagnosed with lung cancer this year, according to the American Lung Association’s “State of Lung Cancer” report. Unfortunately, only 24% of cases nationally are diagnosed at an early stage when the five-year survival rate is much higher. The good news is that the lung cancer five-year survival rate has increased to 23.7% thanks in part to lung cancer screening and advanced technology.
“The strides we have made in lung cancer survival, detection and treatment over the past decade are truly incredible. We have a tremendous opportunity to detect cancer earlier and save lives through lung cancer screening, specifically,” said Harold Wimmer, National President and CEO of the American Lung Association. “Lung cancer screening was first recommended in 2013, so many people still aren’t aware that this may be available to them. If lung cancer is detected early, there are now technologies available to quickly remove it and cure the lung cancer with shorter recovery times.”
Lung cancer screening is key to early detection of the disease. A person is eligible for lung cancer screening if they meet the following criteria:
50 – 80 years of age
Have a 20 pack-year history (1 pack/day for 20 years, 2 packs/day for 10 years;
AND, are a current smoker, or have quit within the last 15 years
If a nodule is detected during screening, new technologies are available that can help biopsy the nodule such as robotic assisted bronchoscopy. Lung cancer can be managed through minimally invasive surgery with a shorter recovery time. Surgery is best performed before a tumor has spread and may not be right for all patients. It is important for people to speak to their healthcare provider about all available management options.
To improve early detection and management of lung cancer, the American Lung Association, with support from Intuitive, launched a new educational campaign. Find out if you are eligible for lung cancer screening by taking a simple quiz here and learn more about the new campaign here.
About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, which has a 4-star rating from Charity Navigator and is a Gold-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.
American Lung Association • 55 W. Wacker Drive, Suite 1150 • Chicago, IL 60601
1331 Pennsylvania Ave. NW, Ste. 1425 North • Washington, D.C. 20004
1-800-LUNGUSA (1-800-586-4872) Lung.org
CONTACT: Jill Dale | American Lung Association
P: 312-940-7001 E: Media@Lung.org
View original content:https://www.prnewswire.com/news-releases/new-technologies-expedite-timeframe-from-screening-to-intervention-for-patients-with-lung-cancer-301673802.html
SOURCE American Lung Association
Veru stock collapsed Thursday after the FDA's advisors voted against the company's cancer drug turned Covid treatment.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) announced confirmatory topline data from the final analysis of results from its Phase 1/2 trial of galinpepimut-S (GPS). The trial assessed GPS in combination with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) for WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian cancer. Median Overall Survival (OS) was 18.4 months compared to 13.8 months in a checkpoint inhibitor single-agent study. Also Read: SELLAS Life Sciences T
Shares of biopharmaceutical company TG Therapeutics (NASDAQ: TGTX) climbed 63.37% on Thursday. TG Therapeutics focuses on therapies to treat B-cell diseases. The company said that the Food and Drug Administration (FDA) had accepted the company's Biologics License Application (BLA) for Ublituximab and had set a Prescription Drug User Fee Act goal date of Dec. 28.
One person died, a woman lost her pregnancy, and over a dozen others were sickened in a listeria outbreak believed to be linked to deli meat and cheese, public health officials said Wednesday.
Story at a glance Breast cancer is the second leading cause of cancer death in U.S. women, while Black women are more likely to die from the disease than white women. New findings from researchers at the University of Washington suggest a DNA vaccine could help treat an aggressive form of the disease. Researchers are…
Kodiak Sciences (KOD) reports a narrower-than-expected loss for the third quarter of 2022. The focus is on the lead candidate, KSI-301, developed for treating various retinal vascular diseases.
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the third quarter ended September 30, 2022, and provided a clinical and corporate update.
The Massachusetts life sciences industry is rife with companies developing drugs and devices to tackle serious diseases, inking new partnership deals, raising money, expanding facilities and more. Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of health care happenings. Inhibikase slapped with clinical hold The U.S. Food and Drug Administration has ordered a stop to a Phase 1 trial of a drug made by Inhibikase Therapeutics Inc. (Nasdaq: IKT), which has offices in Lexington.
Country Music Hall of Famer Alan Jackson revealed Tuesday that he has been diagnosed with the health condition CMT disease. Here's what we know.
The veteran pharmaceutical executive takes charge after the failed launch of Biogen’s once-promising Alzheimer’s disease drug Aduhelm.
AstraZeneca PLC said it had dropped plans to submit its Covid-19 vaccine to the Food and Drug Administration for approval, ending a long-running ambition to eventually sell the shot in the U.S. despite initial setbacks. The Cambridge, England-based pharmaceutical company said Thursday that there would likely be a lack of demand in the U.S., where it said primary vaccination needs had been met. It would continue to focus its efforts on ensuring the availability of the vaccine, called Vaxzevria, elsewhere, including seeking its approval as a booster shot, the company said.
The push to legalize marijuana for recreational in deep-red states stalled on Tuesday
By Faith Ashmore, Benzinga
Federal health officials are conducting a new study to determine whether veterans once stationed at a now-shuttered California military base were exposed to dangerously high levels of cancer-causing toxins. The decision by the Centers for Disease Control and Prevention comes nine months after an Associated Press investigation found that drinking water at Fort Ord contained toxic chemicals and that hundreds of veterans who lived at the central California coast base in the 1980s and 1990s later developed rare and terminal blood cancers. In a letter last Friday to Rep. Katie Porter, D-Calif., the director of the CDC’s Agency for Toxic Substances and Disease Registry, Patrick Breysse, wrote that “there are sufficient data and scientific reasons for ATSDR to re-evaluate health risks related to historical drinking water exposures at Fort Ord.”
A recent "Saturday Night Live" sketch called "Thanks, COVID" — a satirical advertisement promoting getting infected with a virus that's killed over a million Am
With no known cure for dementia, researchers, scientists, and the medical community have long been focused on preventative measures and early diagnosis of this devastating condition. Recognizing the early symptoms is crucial, since a speedy diagnosis allows for the possibility of more effective treatment or management.Researchers are also learning more about the kinds of foods, drinks, and medications that can potentially spike your risk of dementia—sometimes with surprising results. For example
Biogen Inc. has finally announced a new CEO, six months after Michel Vounatsos said he would be stepping down.
Share of EQRx plunged 28.6% after the drugmaker said it would sell two cancer drugs at market prices, instead of the cut-rate prices it had promised.
Three Marylanders became infected with Listeria associated with an outbreak across six states, according to the Centers for Disease Control and Prevention. One death has been reported from Maryland, the CDC said. So far, 16 people are infected with the outbreak strain of Listeria. The other states include California (one), Illinois (two), Massachusetts (two), New Jersey (one) and New York (seven). The CDC said at least 13 people have been hospitalized, and one person got sick during their pregnancy, resulting in the loss of the child.
(Reuters) -The risk of death, hospitalization and serious health issues from COVID-19 jumps significantly with reinfection compared with a first bout with the virus, regardless of vaccination status, a study published on Thursday suggests. "Reinfection with COVID-19 increases the risk of both acute outcomes and long COVID," said Dr. Ziyad Al-Aly of Washington University School of Medicine in St. Louis. The findings were drawn from U.S. Department of Veterans Affairs (VA) data collected from March 1, 2020 through April 6, 2022 on 443,588 patients with one SARS-CoV-2 infection, 40,947 with two or more infections, and 5.3 million noninfected individuals.